Medprin Regenerative Medical Technologies Past Earnings Performance
Past criteria checks 5/6
Medprin Regenerative Medical Technologies has been growing earnings at an average annual rate of 1.1%, while the Medical Equipment industry saw earnings growing at 8.9% annually. Revenues have been growing at an average rate of 18.4% per year. Medprin Regenerative Medical Technologies's return on equity is 7.4%, and it has net margins of 19.7%.
Key information
1.1%
Earnings growth rate
-8.4%
EPS growth rate
| Medical Equipment Industry Growth | 16.0% |
| Revenue growth rate | 18.4% |
| Return on equity | 7.4% |
| Net Margin | 19.7% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Medprin Regenerative Medical Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 244 | 48 | 121 | 26 |
| 31 Dec 23 | 231 | 41 | 116 | 27 |
| 30 Sep 23 | 202 | 31 | 104 | 27 |
| 30 Jun 23 | 186 | 27 | 99 | 29 |
| 31 Mar 23 | 202 | 37 | 107 | 31 |
| 01 Jan 23 | 195 | 36 | 106 | 31 |
| 30 Sep 22 | 190 | 43 | 101 | 33 |
| 30 Jun 22 | 180 | 45 | 95 | 31 |
| 31 Mar 22 | 159 | 41 | 80 | 28 |
| 01 Jan 22 | 154 | 45 | 73 | 26 |
| 30 Sep 21 | 145 | 46 | 66 | 19 |
| 30 Jun 21 | 140 | 42 | 62 | 17 |
| 31 Mar 21 | 137 | 43 | 63 | 17 |
| 31 Dec 20 | 124 | 37 | 60 | 16 |
| 31 Dec 19 | 113 | 28 | 65 | 18 |
| 31 Dec 18 | 86 | -19 | 80 | 21 |
| 31 Dec 17 | 54 | -19 | 69 | 21 |
Quality Earnings: 301033 has high quality earnings.
Growing Profit Margin: 301033's current net profit margins (19.7%) are higher than last year (18.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 301033 has become profitable over the past 5 years, growing earnings by 1.1% per year.
Accelerating Growth: 301033's earnings growth over the past year (31.3%) exceeds its 5-year average (1.1% per year).
Earnings vs Industry: 301033 earnings growth over the past year (31.3%) exceeded the Medical Equipment industry -1.4%.
Return on Equity
High ROE: 301033's Return on Equity (7.4%) is considered low.